Introduction Osteosarcoma is an extremely rare form of cancer that primarily affects children and adolescents.1 It is characterized by the development of bone tumors, and there is a high incidence in teenagers and a second peak in adults older than 65, which is often associated with chronic bone diseases such as Paget’s disease.2,3 The global […]
Introduction Nearly 300,000 women in the United States (US) will be diagnosed with breast cancer in 2022, with an estimated 43,250 deaths.1 Approximately 6% of newly diagnosed breast cancer patients are reported to be de novo metastatic (stage IV disease) at the time of diagnosis, among whom the 5-year survival rate was 29%.1 In addition, approximately […]
Practice patterns by type of operation In total, there were 18,216 appendiceal tumors in the study group, including 1,970 (11%) GCA, 6,219 (34%) mucinous adenocarcinoma, 5,603 (31%) NEN, and 4,424 (24%) non-mucinous adenocarcinoma tumors. A majority of all patients were treated with RHC (60%). Overall, RHC was most frequently performed in GCA (69%) and least […]
Thom Filicia discusses bone marrow donation and myelofibrosis. Courtesy of GSK. It’s been a decade since Thom Filicia, acclaimed interior designer and former co-star of “Queer Eye for the Straight Guy,” served as a bone marrow donor for his brother, Jules, who had received a diagnosis of myelofibrosis. “It was a disease I knew nothing […]
Halloween wasn’t the only event in October worth celebrating. In the October episode of Snap Recap, CancerNetwork® reviews key news items as decided on by our readers. This included articles on the effectiveness of reducing ctDNA tumor fractions with neoadjuvant chemotherapy in triple-negative breast cancer, the benefits of hypofractionated vs standard radiotherapy for breast cancer, […]
CURE and Incyte Corporation are proud to host the 2023 MPN Heroes recognition ceremony, an evening of gratitude and celebration of the heroes who have made a significant impact in the lives of patients with myeloproliferative neoplasms, or MPNs. CRANBURY, N.J., Nov. 16, 2023 (GLOBE NEWSWIRE) — CURE Media Group, the industry-leading multimedia platform devoted to providing […]
CURE Media Group® announces Jane Fonda as keynote speaker for the 2023 MPN Heroes® recognition program News Home Thursday, November 16, 2023 10:38 AM | GlobeNewswire via QuoteMedia CURE Media Group® announces Jane Fonda as keynote speaker for the 2023 MPN Heroes® recognition program CURE and Incyte Corporation are proud to host the 2023 MPN Heroes […]
Introduction Therapies targeting programmed death 1 (PD1) and its ligand (PD-L1), as well as CTL-associated protein 4 (CTLA-4), referred to ICI, exhibit remarkable survival benefits compared to conventional treatments.1–4 Over the decades, the application of ICI has demonstrated promising results in treating LUAD patients.5–7 Nevertheless, a primary worry revolves around the inadequate patient response rate […]
